Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity

Xianting Ding1 Department of Mechanical and Aerospace Engineering, UCLA, Los Angeles, CA, USA

David Jesse Sanchez2 Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA;3 Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA, USA

Arash Shahangian2 Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA

Ibrahim Al-Shyoukh1 Department of Mechanical and Aerospace Engineering, UCLA, Los Angeles, CA, USA;4 Molecular and Medical Pharmacology Department, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA

Genhong Cheng2 Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA

Chih-Ming Ho1 Department of Mechanical and Aerospace Engineering, UCLA, Los Angeles, CA, USACorrespondence[email protected]

Pages 2281-2292 | Published online: 10 May 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ImmingPSinningCMeyerADrugs, their targets and the nature and number of drug targetsNat Rev Drug Discov200651082183417016423
PubMed Web of Science ®Google Scholar
ZhengCJHanLYYapCWJiZLCaoZWChenYZTherapeutic targets: Progress of their exploration and investigation of their characteristicsPharmacol Rev200658325927916714488
PubMed Web of Science ®Google Scholar
PappBPalCHurstLDMetabolic network analysis of the causes and evolution of enzyme dispensability in yeastNature2004429699266166415190353
PubMed Web of Science ®Google Scholar
PilpelYSudarsanamPChurchGMIdentifying regulatory networks by combinatorial analysis of promoter elementsNat Genet200129215315911547334
PubMed Web of Science ®Google Scholar
PengXHKarnaPCaoZHJiangBHZhouMXYangLCross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1 alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expressionJ Biol Chem200628136259032591416847054
PubMed Web of Science ®Google Scholar
OverallCMKleifeldOTumour microenvironment – Opinion – Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNat Rev Cancer20066322723916498445
PubMed Web of Science ®Google Scholar
KeithCTBorisyAAStockwellBRMulticomponent therapeutics for networked systemsNat Rev Drug Discov200541711015688074
PubMed Web of Science ®Google Scholar
KitanoHInnovation – a robustness-based approach to systems-oriented drug designNat Rev Drug Discov20076320221017318209
PubMed Web of Science ®Google Scholar
HuangSRational drug discovery: what can we learn from regulatory networks?Drug Discov Today2002720S16316912546900
PubMed Web of Science ®Google Scholar
RyanQIbrahimACohenMHFDA drug approval summary: Lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2Oncologist200813101114111918849320
PubMed Web of Science ®Google Scholar
BorisyAAElliottPJHurstNWSystematic discovery of multicomponent therapeuticsP Natl Acad Sci U S A20031001379777982
Web of Science ®Google Scholar
O’HaraMKieferDFarrellKKemperKA review of 12 commonly used medicinal herbsArch Fam Med1998765235369821826
PubMedGoogle Scholar
TugwellPPincusTYocumDCombination therapy with cyclosporine and methotrexate in severe rheumatoid arthritisNew Engl J Med199533331371417791814
PubMed Web of Science ®Google Scholar
LawMRWaldNJMorrisJKJordanREValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBrit Med J200332674041427143112829555
PubMed Web of Science ®Google Scholar
GuptaRWarrenTWaldAGenital herpesLancet200737096052127213718156035
PubMed Web of Science ®Google Scholar
KoelleDMCoreyLHerpes simplex: Insights on pathogenesis and possible vaccinesAnnu Rev Med20085938139518186706
PubMed Web of Science ®Google Scholar
BurnsWHSantosGWSaralRIsolation and characterization of resistant herpes-simplex virus after acyclovir therapyLancet1982182694214236121091
PubMed Web of Science ®Google Scholar
De ClercqEAntiviral drugs in current clinical useJ Clin Virol200430211513315125867
PubMed Web of Science ®Google Scholar
RongQAlexanderTSKoskiGKRosenthalKSMultiple mechanisms for HSV-1 induction of interferon alpha production by peripheral blood mononuclear cellsArch Virol2003148232934412556996
PubMed Web of Science ®Google Scholar
ChenSHOakesJELauschRNSynergistic anti-HSV effect of tumor-necrosis-factor-alpha and interferon-gamma in human corneal fibroblasts is associated with interferon-beta inductionAntivir Res199322115298250541
PubMed Web of Science ®Google Scholar
FeduchiECarrascoLMechanism of inhibition of HSV-1 replication by tumor-necrosis-factor and interferon-gammaVirology199118028228251846503
PubMed Web of Science ®Google Scholar
DempseyPWDoyleSEHeJQChengGHThe signaling adaptors and pathways activated by TNF superfamilyCytokine Growth F R2003143–4193209
PubMed Web of Science ®Google Scholar
WongPKYuFQShahangianAChengGHSunRHoCMClosed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithmP Natl Acad Sci U S A20081051351055110
Web of Science ®Google Scholar
TsutsuiHValamehrBHindoyanAAn optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cellsNat Commun2011216721266967
PubMedGoogle Scholar
SunCPUsuiTYuFIntegrative systems control approach for reactivating Kaposi’s sarcoma-associated herpesvirus (KSHV) with combinatory drugsIntegr Biol (Camb)20091112313019851479
PubMed Web of Science ®Google Scholar
LiuMYRakowskiBGershburgEICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 genePlos One201051e883720098619
PubMed Web of Science ®Google Scholar
ElliottGO’HarePLive-cell analysis of a green fluorescent protein-tagged herpes simplex virus infectionJ Virol19997354110411910196307
PubMed Web of Science ®Google Scholar
StornRPriceKDifferential evolution – a simple and efficient heuristic for global optimization over continuous spacesJ Global Optim1997114341359
Web of Science ®Google Scholar
KakudaTNBrinkmanKMitochondrial toxic effects and ribavirinLancet200135792701802180311407388
PubMed Web of Science ®Google Scholar
De FranceschiLFattovichGTurriniFHemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damageHepatology2000314997100410733558
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date